webinar register page

ASTEM Webinar: 29 April 2022

The cell and gene therapy market continues to advance with a significant impact on healthcare. As a cell therapy developer, qualifying raw materials used in your manufacturing process is critical to success in your translational journey. To help you reduce time and costs for translational projects, STEMCELL will walk you through key regulatory considerations that may determine the success of your clinical candidates.
This webinar is a part of the series organised by the Allogeneic STEM Cell Manufacturing Programme (ASTEM), which seeks to transform cellular therapy through enhanced donor selection and the establishment of highly robust mesenchymal stem cells with proven efficacy. This programme is funded by the Agency of Science Technology and Research (A-STAR), includes the partner institutions of IMCB, BTI, GIS and NUH and works extensively with industry to create new technologies and solutions to improve the isolation and generation of adequate MSCs with high therapeutic potency to meet market demands.

Apr 29, 2022 11:00 AM in Singapore